Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer. [PDF]
Sobhani N +4 more
europepmc +3 more sources
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. [PDF]
Okajima W +14 more
europepmc +3 more sources
5th Central-Eastern European Congress on Cell-Free Nucleic Acids
21st-22nd June, 2018.
-
doaj +1 more source
Synergistic Upregulation of Extracellular Vesicles and Cell-Free Nucleic Acids by Chloroquine and Temozolomide in Glioma Cell Cultures. [PDF]
Aleksandrov AE +6 more
europepmc +3 more sources
Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma. [PDF]
Li S, Zhang E, Cai Z.
europepmc +3 more sources
Cell-Free Nucleic Acids as Biomarkers of Biocompatibility in Dialytic Process [PDF]
In this review we describe what is recently known about the origin of free nucleic acids in human circulation, which processes can cause the elevations of their total concentrations and the alterations in the ratios among different types of circulating nucleic acids in human plasma and serum.
Marie Korabečná, Aleš Hořínek
openalex +4 more sources
Cell-Free Nucleic Acids for Early Diagnosis of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. [PDF]
Zhang X +9 more
europepmc +3 more sources
Simple and Low-Cost Sampling of Cell-Free Nucleic Acids from Blood Plasma for Rapid and Sensitive Detection of Circulating Tumor DNA. [PDF]
Jin CE +6 more
europepmc +3 more sources
Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review. [PDF]
Morisi N +6 more
europepmc +3 more sources
Liquid Biopsy as a Method for Minimally Invasive Diagnosis of Thyroid Cancer [PDF]
Thyroid cancer is the 9th most common cancer in the world. The five-year survival rate for this disease is over 98%. However, in some patients there are cases of rapidly progressive treatment-resistant cancer that cannot be differed from poor-invasive ...
Tagir I. Rakhmatullin +3 more
doaj +1 more source

